Suscribirse

FRA-1: A key factor regulating signal transduction of tumor cells and a potential target molecule for tumor therapy - 27/05/22

Doi : 10.1016/j.biopha.2022.113037 
Feng Zeng a, b, 1, Junyu He a, b, 1, Xi Jin a, b, Qianjin Liao a, Zhifang Chen c, Honghua Peng d, , Yanhong Zhou a, b,
a NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China 
b Cancer Research Institute, Basic School of Medicine, Central South University, Changsha, Hunan 410078, China 
c Department of Gynecology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China 
d Department of The Oncology, Third Xianya Hospital, Xiangya School of Medicine, Central South University, 138 Tongzipo Road, Changsha, Hunan 410013, China 

Corresponding author.⁎⁎Correspondence to: NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China.NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityChangshaHunan410013China

Abstract

Fos-related antigen-1 (FRA-1) is a member of activator protein-1 (AP-1) transcription factor superfamily, and FRA-1 is highly expressed in colon cancer, breast cancer, gastric cancer, lung cancer, bladder cancer, and other tumors. The expression level of FRA-1 is closely related to the processes of tumor cell proliferation, apoptosis, transformation, migration, and invasion, which is a potential therapeutic target and prognostic factor for many tumors. Clarifying the detailed mechanism of action of FRA-1 could provide the theoretical basis for tumor diagnosis, treatment, and prognosis, and is of great significance for the study of tumor etiology and pathogenesis. In this paper, the expression levels and influencing factors of FRA-1 in various tumor tissues and cells are summarized, as well as the effect of FRA-1 expression level on the biological behavior of tumor cells and the signal transduction mechanism. At the same time, the signal transduction mechanism of FRA-1 in inflammation was expounded. In addition, the related metabolites, drugs and non-coding RNA that affect the expression and function of FRA-1 were summarized. Finally, it illustrates that FRA-1 may be taken as a key factor for tumor prognosis and a potential therapeutic target. This review provides a theoretical basis for the systematic understanding of the relationship between FRA-1 and tumors, its function, and possible mechanism.

El texto completo de este artículo está disponible en PDF.

Graphical Abstract




ga1

El texto completo de este artículo está disponible en PDF.

Highlights

FRA-1 is closely related to the processes of tumor cell proliferation, apoptosis, transformation, migration, and invasion.
FRA-1 plays a key role in regulating inflammatory reaction, and interleukin signal transduction related gene expression.
FRA-1 can promote the proliferation or apoptosis of cancer cells by regulating PI3K/AKT and other signaling pathways.
Some drugs, non-coding RNA and other small molecules can regulate the expression and function of FRA-1.

El texto completo de este artículo está disponible en PDF.

Keywords : FRA-1, Tumor, Pathogenesis, Prognosis, Biological characteristics


Esquema


© 2022  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 150

Artículo 113037- juin 2022 Regresar al número
Artículo precedente Artículo precedente
  • Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents
  • Sheema Hashem, Tayyiba Akbar Ali, Sabah Akhtar, Sabah Nisar, Geetanjali Sageena, Shahid Ali, Sharefa Al-Mannai, Lubna Therachiyil, Rashid Mir, Imadeldin Elfaki, Mohammad Muzaffar Mir, Farrukh Jamal, Tariq Masoodi, Shahab Uddin, Mayank Singh, Mohammad Haris, Muzafar Macha, Ajaz A. Bhat
| Artículo siguiente Artículo siguiente
  • Mechanistic approach towards diabetic neuropathy screening techniques and future challenges: A review
  • Rashmi Pathak, Neetu Sachan, Phool Chandra

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.